A direct competitive enzyme-linked immunosorbent assay (ELISA) screening method for zearalenone in corn, wheat, and feed at 500 nglg was evaluated by 23 collaborators (22 laboratories) in an international collaborative study. Eighteen samples of spiked or naturally contaminated corn, wheat, and pig feed were prepared by the sponsoring laboratory and sent for testing with complete test kits to participating collaborators in Canada, Italy, Sweden, The Netherlands, and the United States. Test samples were extracted with methanolwater solution (70 + 30) by shaking on a wrist-action shaker for 3 min. A portion of the extract was mixed with an equal volume of zearalenone-enzyme conjugate, and the mixture was incubated with zearalenone-specific monoclonal antibodies coated onto microtiter wells. All test samples were assayed in duplicate. One of 52 (2%) blanks was reported positive. Thirty-nine of the 52 (75%) samples that were spiked at 500 nglg were reported as positive. Forty-nine of the 51 (96%) samples with concentrations at or above 1000 nglg were reported as positive. The overall incidence of false negatives was 6.0% and the incidence of false positives was 22.7% by the ELISA method. Only one (3.4%) false negative was reported for samples containing 800 nglg. In the spectrophotometric method, 8 collaborators determined approximate levels of zearalenone in test samples from standard curves constructed from spiked extracts (0-3000 nglg of each commodity tested). This method gave and overall incidence of false negatives of 5.7% and false positives of 17.8%. Average relative standard deviations, RSD r (repeatability) and RSDR (reproducibility), were 11.6 and 25.1% for spiked samples and 11.7 and 33.1% for naturally contaminated samples, respectively. Standard curves were constructed with each set of samples assayed. Comparison of absorbance values from these standard curves indicate the performance of reagents and antibody used in the assay. The ELISA method has been adopted first action by AOAC INTERNA-TIONAL as a screening method for zearalenone at 800 nglg in corn, wheat, and pig feed.
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earalenone [6-( 1O-hydroxy-6-oxo-trans-l-undecenyl)--resorcylic acid lactone] is a secondary metabolite produced by toxigenic Fusarium spp. that colonize a number of cereal crops both in the field and in storage (1) . The biological effects of this mycotoxin require that its presence in human foods and animal feeds be closely monitored because contamination of cereals occurs worldwide (2) . Current analytical methods for zearalenone such as thin-layer chromatography (3-5), gas liquid chromatography (6, 7), liquid chromatography (LC) (8) (9) (10) (11) , and mass spectrometry/mass spectrometry (12) require time-consuming extraction and cleanup, and most involve expensive instrumentation. As an alternative procedure, an immunoassay for detecting zearalenone in agricultural commodities has recently been developed (13) . This method has been improved by developing a direct competitive enzyme-linked immunosorbent assay (ELISA) protocol (14) and incorporating a specific monoclonal antibody to zearalenone and a-zearalenol into the assay (15) . The ELISA procedure has been used to survey grainbased food products for zearalenone (16) .
The current collaborative study was conducted to validate an ELISA procedure to screen for the presence of zearalenone in com, wheat, and pig feed at ;::SOO ng/g.
Collaborative Study

Preparation of Samples
Toxin-free and naturally contaminated batches (2-5 kg) of yellow dent com, wheat, and pig feed were ground to pass a No. 20 sieve, using a Jacobson mill equipped with a screen having 1;8 in. diameter round-hole perforations. Each batch was blended 20 min in a Hobart planetary mixer. All test samples (20 g each) were weighed into wide-mouth polypropylene containers with attached snap-on covers. Spiked samples were prepared by adding known amounts of zearalenone (in methanol) to pre-weighed test samples. Solvent was allowed to evaporate and the containers were sealed. Levels of zearalenone in the naturally contaminated products were determined, in triplicate, by LC (11). Collaborators were instructed to use entire sample for assay.
Reference Standards and Controls
The purity of the standards was determined to be >98% by gas chromatography and UV absorption spectra (17) . Controls for the collaborators using the visual method to detect zearalenone were prepared by adding standard zearalenone to methanol-water (70 + 30) extracts from toxin-free com, wheat, and pig feed so that the concentration was 500 ng zearalenone/g. Extracts to construct standard curves for the spectrophotometric method portion of the study were prepared by adding the appropriate amount of zearalenone (0, 500, and 1000 ng/g). Color development in practice samples (negative, target level, and positive samples) were compared with controls containing 500 ng zearalenone/g in extracts of toxin-free com or pig feed. Two controls were run with each practice set.
Description of Study
Visual Method
Each of 15 collaborators received 18 coded test samples including 6 sets of blind duplicates of spiked and naturally contaminated samples of com, wheat, and feed (0-2570 ng zearalenone/g). In addition, each collaborator received 2 sets of practice samples (each set contained 3 com and 3 feed samples) with noted levels of zearalenone (0, 500, and 1000 ng/g) for familiarization with assay and color development.
The collaborators visually determined if coded test samples were positive or negative for zearalenone by comparing color development in samples to color development in controls containing 500 ng zearalenone/g.
Spectrophotometric Method
Eight collaborators determined spectrophotometrically approximate levels of zearalenone in the 18 coded test samples. Zearalenone levels were interpolated from standard curves constructed from spiked extracts of each matrix that contained 
A. Principle
Detection of zearalenone is based on competitive binding enzyme immunoassay using specific monoclonal antibodies.
Zearalenone is extracted with methanol-water (70 + 30). Extract is fJ.ltered and mixed with equal volume of zearalenoneenzyme conjugate. Samples and controls are placed into microtiter wells coated with zearalenone-specific monoclonal antibodies. Zearalenone present in sample attaches to specific antibodies adsorbed on well. Wells are washed to remove unbound zearalenone and zearalenone-enzyme conjugate and activated enzyme substrate is added. After stop solution is added, concentration of zearalenone in sample depends, inversely, on intensity of color development and is determined visually or spectrophotometrically (approximate levels of zearalenone are interpolated from standard curve).
B. Antibody Specificity
Anti-zearalenone antibodies bind zearalenone analogues, especially a-zearalenol. The cross-reactivity is similar for zearalenone and ex-zearalenol (100% and 107%, respectively).
Cross-reactivities to other zearalenone analogues are:~ zearalenol, 29%; ex-zearalanol, 35%;~-zearalanol, 25%. Standard curves constructed with zearalenone standard solutions (0-3000 ng/g) provide quality control measure for analytical stability.
C. Apparatus (i) Standard solutions.-Teflon-lined, screw-capped amber vials containing toxin-free com, wheat, and feed extracts (methanol-water) spiked with zearalenone at levels (ng/g): 0, 200,500, 1000, 1500, and 3000. Prepare standard curve at time samples are tested.
Items (a)-{g) are available as Agri-Screen Kit for Zearalenone (Neogen Corp., 620 Lesher PI., Lansing, Ml 4S912). Validated, alternative reagents are acceptable.
E. General Instructions
Store test samples, reagents, and kit components at 4°-S O C. Do not freeze. Bring reagents and kit components to room temperature (20°-25°C) prior to use. Reagents are stable at room temperature:::::S h. Return reagents to 4°-S"C after use. Assay one set of samples (6/set) at a time. Assay each set twice. Determine results (color development) after stop solution is added.
F Sample Extraction
Carefully transfer 20 g sample to 500 mL glass-stopper or screw-cap extraction flask. Add 200 mL methanol-water solution (70 + 30), close lightly, and shake for 3 min on wrist-action shaker, C(a). Filter through Whatrnan 2V filter paper, C(c).
Collect ca 4 mL. Collect and save second 4 mL portion in case of accidental loss offirst fraction. Analyze sample immediately or transfer to screw-cap vial and store at 4°-SoC for :::::24 h.
G. Preparation of Reagent Solutions
Bring reagents to room temperature (20o-25°C) prior to use. Repeat steps (a)-(k). Results from both assays should agree. Positive results must be confirmed by AOAC method 985.18.
I. Zearalenone Determination by Spectrophotometric Method
Perform as in H(a)-{j) using l2-well microtiter strips of mixing wells and antibody coated wells, D(c) (see Figure 994.01B ). Use one uncoated well from black marked package to blank microtiter well reader, I(a). 
Results and Discussion
Twenty-three of 25 collaborators completed the study and submitted data. Two collaborators who initially planned to perform spectrophotometric determinations reported visual results because of lack of the proper fIlter for the microtiter well reader. Although all collaborators commented that the instructions and procedures for the visual method were easy to understand, 4 collaborators failed to perform duplicate assays on all samples as requested.
The results of the visual method are presented in Tables 1  and 2 . Sample 3 ( Table 1 ) and sample 4 ( Table 2) were inadvertently mixed by Collaborator 10 and, therefore, listed as lost samples. For statistical purposes, each assay was considered an independent measurement and the percent positive response was calculated using all assay results. The percent positive responses were: 2% at 0 ng/g, 63% at 300 ng/g, 75% at 500 ng/g, and 96% at 800 ng zearalenonelg. No negative responses were reported at levels above 800 ng zearalenone/g. Positive rates and 95% confIdence intervals (18) for all samples are listed in Table 3 . One set of duplicates (pig feed at 352 ng zearalenone/g) was not consistent with other data, which showed increasing numbers of positive values as the zearalenone level increased. This set of duplicates had 4 outliers (-/+ samples). The average recovery for this sample was 72%. Because only 75% of samples at 500 ng zearalenone/g were correctly identified, the procedure, as tested in this study, is a reliable screening method only when zearalenone is present at ;;:::800 ng/g. Analysis of sensitivity and specificity was done on 2 different levels. At the first level, each result was considered independently of other results with 11 laboratories reporting 2 results for each sample and 4 laboratories reporting one result for a total of 26 assays for each sample (unless otherwise noted in Tables 1 and 2 ). The second level was based on laboratory performance; a pair of negatives was considered as negative for that laboratory and a pair of positives or (+/-) or (-/+) results was considered as positive for that laboratory. The reason for such interpretation was that a pair of negatives would result in no further action, while 2 positives would be a condition for possible further testing. The 4 laboratories that reported one result per sample were scored as per that one result.
Overall, by assay, the sensitivity was 94.3% (247 positives out of 262 assays at levels 500, 800, 1000, 1027, 1295, and 2570 ng zearalenone/g) and the specificity was 78.1 % (164 negatives out of21O assays at levels 0, 215, 247, 300, and 352 ng zearalenone/g). By laboratories, the sensitivity was 94.0% (140 of 149) and the specificity was 74.8% (89 of 119). 12 with a standard error of 0.015 is used, it could be predicted that the positive results at a level of 500 ng zearalenone/g would be 60% (± 7.5%).
If 500 ng zearalenone/g or greater is considered the target level for a "true" positive, then the overall incidence of false negative and false positive samples was 6.0 and 22.7%, respectively. Only one false negative sample was reported at 800 ng/g and this sample (No.3) accounts for a false negative value of 3.4%. The source of this error could not be determined; however, the same collaborator (No.5) also reported conflicting values on 3 other samples (No. 11, 21, and 25). The assays were completed 70 days after manufacture of kit components (date of expiration). Samples identified as positive by this e n =number of assays. screening procedure should be analyzed by the AOAC Official Method 985.18 to detennine actual levels of zearalenone.
Eight collaborators determined approximate levels of zearalenone spectrophotometrically. Levels were interpolated from standard curves prepared for a set of samples and each sample was assayed twice. Although repeatability could have been improved if the sample extract had been assayed twice on adjacent antibody-coated wells, the procedure used tested the reliability and strip-to-strip variation of the wells. Data from 48 standard curves (240 data points) were analyzed to determine average percent absorbance that should be expected at the 5 different zearalenone concentrations used in the study. A summary of this data is shown in Table 4 . One set of data (6 curves from Collaborator 15) was omitted as an outlier. These data were inconsistent with all other data, in the following ways: values greater than 100% were reported, and the percent absorbance values for the other commodities were always lower than those of other collaborators. The assays were the last ones performed in the study (74 days after kit components were manufactured) and the samples and kits were stored until the microtiter-well reader was repaired. Post-study assays of retention samples verified that the kit components were still reliable. Obvious well-failure rate or operator error resulted in omission of 5 of the 210 (2.4%) remaining data points. Consistency of average absorbency values for the different commodities indicate that assay results are not influenced by substrate from which zearalenone is extracted.
Results of the spectrophotometric method are listed in Tables 5 and 6. Ranking of laboratories by the Youden and Steiner test (19) confirmed that data from Collaborator 15 were outliers because the sum for all duplicates was low in all cases except one. Duplicate sums reported by Collaborator 24 were high for 3 of 6 duplicates; however, standard-curve data were consistent with other collaborators and removal of additional collaborators would affect the validity of the study. Three individual values were omitted as outliers by Dixon's test (19) and/or apparent kit component failure. Two of these values were for sample 21 (pig feed at 0 ng zearalenone/g). Duplicate assays gave results that were greater than the standard (200 ng zearalenone/g) and indicated operator error or microtiter well failure. No additional outliers were found by the Cochran or single-Grubbs tests. Analysis of variance on blind duplicates showed that the average RSD r was 11.6% for spiked samples and 11.7% for naturally contaminated samples. The RSD r was 25.1 and 33.1 % for spiked and naturally contaminated samples, respectively (Table 7) . If500 ng zearalenone/g or greater is the target level for a "true" positive, the number of false positives for this procedure was 10 of56 (17.8%) and the number offalse negatives was 4 ono (5.7%), very similar to rate of the visual method ( Table 8 ).
The spectrophotometric assay results showed higher levels of zearalenone than the added amount (Table 5) or determined by LC in naturally contaminated samples (Table 6 ). The crossreactivity of the antibody to a-zearalenol (107% compared to zearalenone) could account for part of the high recovery for naturally contaminated samples but not from the spiked samples. Comments from collaborators were generally favorable; however, one collaborator was disappointed in variation between runs and suggested doing duplicate assays in adjacent wells rather than using different well strips. One collaborator was uncomfortable with the pre-set spring syringe and preferred a micropipet. A 630 nm filter was used in place of the recommended 650 nm filter; however, results were not adversely affected. Practice samples were helpful mainly to collaborators performing visual assays. The importance of washing microtiter wells to remove unbound antigen and other materials was mentioned and a better procedure for plotting standard curves was requested. One disadvantage to the otherwise simple assay is the persistence of some blue color, prior to the addition of stopping reagent, at the target level of 500 ng zearalenone/g. One collaborator did not like the visual method because the color development was not well-defined at low levels.
In general, all collaborators found that the procedure was simple and easy to use.
